« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 194, Issue 4
, Pages 947.e1-947.e10
, April 2006
Associations between fetal inherited thrombophilia and adverse pregnancy outcomes
References
- . Thrombophilia and pregnancy complications. Am J Obstet Gynecol. 2004;191:412–424
- . Genetic susceptibility to venous thrombosis. N Engl J Med. 2001;344:1222–1231
- . Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol. 1997;177:402–405
- . Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet. 2000;67:986–990
- . Foetal growth restriction in children with prothrombotic risk factors. Thromb Haemost. 2001;86:1012–1016
- Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med. 2002;347:19–25
- . Fetal carriage of folate gene polymorphisms C677T methylenetetrahydrofolate reductase and A2756G methionine synthase are not related to fetal growth restriction. Am J Obstet Gynecol. 2002;187:S184
- . Inherited thrombophilias are not increased in “idiopathic” small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2003;188:981–985
- Fetal inherited thrombophilias influence the severity of preeclampsia, IUGR and placental abruption. Eur J Obstet Gynecol Reprod Biol. 2004;113:31–35
- Inherited risk of thrombosis of the fetus and intrauterine fetal death. Eur J Obstet Gynecol Reprod Biol. 2004;117:45–48
- Associations between inherited thrombophilias, gestational age, and cerebral palsy. Am J Obstet Gynecol. 2005;193:1437;e1-1437 e12
- . Australian national birthweight percentiles by gestational age. Med J Aust. 1999;170:114–118
- . Thrombophilia in pregnancy. J Clin Pathol. 2000;53:573–580
- . Pregnancy and the impact of inherited thrombophilias. Aust N Z J Obstet Gynaecol. 2000;40:118–121
- . High risk of thrombosis in patients homozygous for factor V Leiden (activated protein resistance). Blood. 1995;85:1504–1508
- . Prothrombotic mutations as a risk factor for preterm birth. Lancet. 1999;353:1411–1412
- . Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7–9
- . Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J Clin Invest. 1986;77:1909–1916
- . Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042–1051
- . A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet. 1998;62:1044–1051
- . Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med. 2004;117:26–31
- . Hypertension during pregnancy in South Australia, part 1: pregnancy outcomes. Aust N Z J Obstet Gynaecol. 2004;44:404–409
Supported by The Australian National Health and Medical Research Council, The Channel 7 Children's Research Foundation, The University of Adelaide, and The South Australian Government Captive Insurance Corporation. The supporting sources had no influence on the analysis, writing, or submission of the manuscript.Presented at the 26th Annual Meeting of the Society for Maternal Fetal Medicine, Miami, FL, January 30-February 4, 2006.Supplementary material available at: www.ajog.org.
PII: S0002-9378(06)00186-4
doi: 10.1016/j.ajog.2006.01.111
© 2006 Mosby, Inc. All rights reserved.
« Previous
Next »
American Journal of Obstetrics & Gynecology
Volume 194, Issue 4
, Pages 947.e1-947.e10
, April 2006
